A Primer of Drug Action

Front Cover
Worth Publishers, Oct 12, 2007 - Psychology - 704 pages
4 Reviews
From its first edition 30 years ago, Robert Julienís A Primer of Drug Action has evolved side by side with the field it covers, capturing the current state of the science of psychopharmacology with each new edition.
Furthering that tradition, the new edition takes its place as the definitive guide to the pharmacology of drugs that affect the mind and behavior as understood today.† With over 40% new research citations, there is no clearer, more current presentation available on the mechanisms of drug action, etiologies of major psychological disorders, rationales for drug treatment, and the uses of psychopharmacology in patient care.

What people are saying - Write a review

Review: A Primer of Drug Action

User Review  - Morgan Blackledge - Goodreads

This book was an undertaking. Both exhaustive and at times exhausting. But I literally could not (or rather would not) put this book down. It is packed with essential info on every dang page. Crucial ... Read full review

Review: A Primer of Drug Action

User Review  - Tim - Goodreads

This book has been a life changer for me. It stays on my coffee table much of the time. Read full review

About the author (2007)

The Author
Robert M. Julien, M.D., received his M.S. and Ph.D. in Pharmacology from the University of Washington and his Medical Degree from the University of California at Irvine.† His many research articles focus on the psychopharmacology of sedative and antiepileptic drugs.† Previously an Associate Professor of Pharmacology and Anesthesiology at the Oregon Health Sciences University, he currently practices anesthesiology in Portland, Oregon.†New Contributors
Claire D. Advokat, professor of psychology at LSU, received her Ph.D. from Rutgers University.† Her primary interest is in understanding the clinical effectiveness and the mechanism of action of drugs used in the treatment of mental illness, such as the antipsychotics, antidepressants, mood stabilizers, and anxiolytics.†Joseph Comaty, Adjunct Professor at LSU, received his Ph.D. in clinical psychology from Rosalind Franklin University of Science and Medicine.† His primary area of research is clinical psychopharmacology.† In particular, he is interested in the study of the clinical treatment for the major psychiatric disorders of schizophrenia, major depression, and bipolar disorder.

Bibliographic information